Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$948K Buy
+6,094
New +$1.09M ﹤0.01% 621
2025
Q3
Sell
-8,375
Closed -$1.32M 685
2025
Q2
$1.32M Buy
8,375
+2,350
+39% +$347K 0.01% 561
2025
Q1
$813K Buy
+6,025
New +$841K 0.01% 609
2020
Q3
Sell
-46,127
Closed -$4.32M 819
2020
Q2
$4.32M Buy
46,127
+22,078
+92% +$2.17M 0.05% 363
2020
Q1
$2.3M Hold
24,049
0.03% 504
2019
Q4
$2.35M Sell
24,049
-18,477
-43% -$1.63M 0.03% 518
2019
Q3
$3.65M Buy
42,526
+29,208
+219% +$2.45M 0.05% 382
2019
Q2
$1.06M Buy
+13,318
New +$973K 0.01% 642
2018
Q4
Sell
-8,496
Closed -$588K 833
2018
Q3
$588K Sell
8,496
-369
-4% -$25.1K 0.01% 696
2018
Q2
$523K Buy
8,865
+1,865
+27% +$116K 0.01% 693
2018
Q1
$458K Hold
7,000
0.01% 687
2017
Q4
$452K Buy
+7,000
New +$439K 0.01% 696

Other funds holding LDOS

Candriam SCA's LDOS Position: Q1 2026 in Review

Candriam SCA opened a new position in Leidos (LDOS) in Q1 2026: 6,094 shares worth $948K. The stake represents ﹤0.01% of the portfolio and ranks #621 among its holdings. This is a return to the name: Candriam SCA previously reported a position in LDOS as recently as Q2 2025.

Candriam SCA first reported a position in LDOS in Q4 2017 and has held it in 12 quarters since. The position peaked at $4.32M in Q2 2020. 897 funds tracked by Wall St. Rank hold LDOS as of Q1 2026.

  • Candriam SCA held 6,094 shares of Leidos worth $948K as of Q1 2026.
  • Leidos was a new Candriam SCA position in Q1 2026.
  • Leidos made up ﹤0.01% of Candriam SCA's portfolio in Q1 2026, its #621 holding.
  • Candriam SCA first reported a position in Leidos in Q4 2017 and has held it in 12 quarters since.
  • Candriam SCA's Leidos position peaked at $4.32M in Q2 2020.
  • 897 funds tracked by Wall St. Rank held Leidos as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.